Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)

Author:

Krysko Kristen1,Graves Jennifer2,Rensel Mary3,Weinstock-Guttman Bianca4,Rutatangwa Alice1,Aaen Gregory5,Belman Anita6,Benson Leslie7,Chitnis Tanuja8,Gorman Mark7,Goyal Manu9,Harris Yolanda10,Krupp Lauren6,Lotze Timothy11,Mar Soe12,Moodley Manikum3,Ness Jayne13,Rodriguez Moses14,Rose John15,Schreiner Teri16,Tillema Jan-Mendelt14,Waltz Michael17,Casper T. Charles17,Waubant Emmanuelle1

Affiliation:

1. Neurology, University of California San Francisco

2. Neurology, University of California San Diego

3. Neurology, Cleveland Clinic

4. Neurology, State University of New York at Buffalo

5. Pediatrics, Loma Linda University

6. Neurology, New York University Langone Medical Center

7. Neurology, Boston Children’s Hospital

8. Pediatric Neurology, Massachusetts General Hospital

9. Mallinckrodt Institute of Radiology

10. Nursing

11. Neurology, Texas Children’s Hospital

12. Neurology, Washington University in Saint Louis

13. Pediatrics, University of Alabama at Birmingham

14. Neurology, Mayo Clinic

15. Neurology

16. Neurology & Pediatrics, University of Colorado

17. Pediatrics, University of Utah

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3